Cell therapy in dilated cardiomyopathy: From animal models to clinical trials

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 5, 2011, Pages 388-393

  del Corsso, C ^a   de Carvalho, A C Campos ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cell therapy; Chagas' disease; Dilated cardiomyopathy; Heart failure; Stem cell

Indexed keywords

CELL THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONGESTIVE CARDIOMYOPATHY; DISEASE MODEL; EMBRYONIC STEM CELL; GENE THERAPY; GENETIC ENGINEERING; GENETIC MODEL; HAMSTER; HUMAN; NONHUMAN; REVIEW;

ANIMALIA;

EID: 79958186396     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500047     Document Type: Review

References (33)

1. World Health Organization. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980; 44: 672-673.
2. Braunwald E. Cardiology: how did we get here, where are we today and where are we going? Can J Cardiol 2005; 21: 1015-1017.
3. Maron BJ, Towbin JA, Thience K, Antzelevitch C, Corrado D, Arnett D, et al.Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816.
4. Elliott P, Andersson B, Arbustini Braunwald, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270-276.
5. Rosamond W, Flegal K, Furie K, Go J, Greenlund K, Haase N, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-e146.
6. Chiu RC, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 1995; 60: 12-18.
7. Li RK, Jia ZQ, Weisel RD, Mickle DA, Zhang J, Mohabeer MK, et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996; 62: 654-660.
8. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA. Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 1999; 31: 513-522.
9. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998; 4: 929-933.
10. Watanabe E, Smith DM Jr, Delcarpio JB, Sun J, Smart FW, Van Meter CH Jr, et al. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant 1998; 7: 239-246.
11. Scorsin M, Hagege AA, Dolizy I, Marotte F, Mirochnik N, Copin H, et al. Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation 1998; 98: II-151-II-155.
12. Yoo KJ, Li RK, Weisel RD, Mickle DA, Jia ZQ, Kim EJ, et al. Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation 2000; 102: III-204-III-209.
13. Pouly J, Hagege AA, Vilquin JT, Bissery A, Rouche A, Bruneval P, et al. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 2004; 110: 1626-1631.
14. Suzuki K, Murtuza B, Suzuki N, Smolenski RT, Yacoub MH. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 2001; 104: I-213-I-217.
15. Hata H, Matsumiya G, Miyagawa S, Kondoh H, Kawaguchi N, Matsuura N, et al. Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg 2006; 132: 18-924.
16. Werner L, Deutsch V, Barshack I, Miller H, Keren G, George J. Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis. J Mol Cell Cardiol 2005; 39: 691-697.
17. Roura S, Planas F, Prat-Vidal C, Leta R, Soler-Botija C, Carreras F, et al. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur J Heart Fail 2007; 9: 995-1002.
18. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-637.
19. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
20. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005; 112: 1128-1135.
21. Kondoh H, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Kitagawa-Sakakida S, et al. Reorganization of cytoskeletal proteins and prolonged life expectancy caused by hepatocyte growth factor in a hamster model of late-phase dilated cardiomyopathy. J Thorac Cardiovasc Surg 2005; 130: 295-302.
22. Kondoh H, Sawa Y, Miyagawa S, Sakakida-Kitagawa S, Memon IA, Kawaguchi N, et al. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. Cardiovasc Res 2006; 69: 466-475.
23. Kondoh H, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Kitagawa-Sakakida S, et al. Combined strategy using myoblasts and hepatocyte growth factor in dilated cardiomyopathic hamsters. Ann Thorac Surg 2007; 84: 134-141.
24. Baba S, Heike T, Yoshimoto M, Umeda K, Doi H, Iwasa T, et al. Flk1(+) cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. Cardiovasc Res 2007; 76: 119-131.
25. Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K, Hashiya N, et al. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 2002; 40: 47-53.
26. Arguero R, Careaga-Reyna G, Castano-Guerra R, Garrido-Garduno MH, Magana-Serrano JA, de Jesus Nambo-Lucio. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch Med Res 2006; 37: 1010-1014.
27. Kalil RA, Ott D, Sant'Anna R, Dias E, Marques-Pereira JP, Delgado-Canedo A, et al. Autologous transplantation of bone marrow mononuclear stem cells by mini-thoracotomy in dilated cardiomyopathy: technique and early results. São Paulo Med J 2008; 126: 75-81.
28. Strauer BE, Heidland UE, Heintzen MP, Schwartzkopff B. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. J Am Coll Cardiol 1996; 28:1119-1126.
29. Widimsky P, Penicka M. Complications after intracoronary stem cell transplantation in idiopathic dilated cardiomyopathy. Int J Cardiol 2006; 111: 178-179.
30. Seth S, Narang R, Bhargava B, Ray R, Mohanty S, Gulati G, et al. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 2006; 48: 2350-2351.
31. Wang JA, Xie XJ, He H, Sun Y, Jiang J, Luo RH, et al. [A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy]. Zhonghua Xin Xue Guan Bing Za Zhi 2006; 34: 107-110.
32. Huang RC, Yao K, Li YL, Zhang YQ, Xu SK, Shi HY, et al. [Transplantation of autologous bone marrow mononuclear cells on patients with idiopathic dilated cardiomyopathy: early results on effect and security]. Zhonghua Xin Xue Guan Bing Za Zhi 2006; 34: 111-113.
33. Martino HF, Oliveira PS, Souza FC, Costa PC, Assunção e Silva E, Villela R, et al. A safety and feasibility study of cell therapy in dilated cardiomyopathy. Braz J Med Biol Res 2010; 43: 989-995.